Citigroup Inc Aveo Pharmaceuticals, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$8.48 - $14.97 $35,149 - $62,050	-4,145 Reduced 84.25%	775 $11,000
Q3 2022 Nov 10, 2022	SELL	$6.61 - $8.72 $2,644 - $3,488	-400 Reduced 7.52%	4,920 $40,000
Q2 2022 Aug 10, 2022	BUY	$3.51 - $6.67 $13,548 - $25,746	3,860 Added 264.38%	5,320 $35,000
Q1 2022 May 12, 2022	BUY	$3.15 - $6.01 $4,599 - $8,774	1,460 New	1,460 $8,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.